Testing effectiveness (Phase 2)Study completedNCT04565756What this trial is testingEvaluate the Safety and Tolerability of EXN407Who this might be right forDiabetic Macular Edema Exonate Limited 48
Early research (Phase 1)Looking for participantsNCT05802329What this trial is testingPhase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)Who this might be right forCenter Involved Diabetic Macular EdemaDiabetic Macular Edema Ocugen 24
Testing effectiveness (Phase 2)Study completedNCT01506895What this trial is testingClinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular EdemaWho this might be right forRetinopathy, Diabetic GlaxoSmithKline 54
Post-approval studies (Phase 4)WithdrawnNCT03059277What this trial is testingIntravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal RanibizumabWho this might be right forDiabetic Macular Edema Southeast Clinical Research Associates, LLC
Not applicableStudy completedNCT04499703What this trial is testingEvaluation of the Retinal Health Monitoring System Thickness ModuleWho this might be right forMacular EdemaMacular Degeneration Kubota Vision Inc. 60
Testing effectiveness (Phase 2)Study completedNCT03466099What this trial is testingStudy of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME)Who this might be right forDiabetic Macular Edema KalVista Pharmaceuticals, Ltd. 129
Testing effectiveness (Phase 2)Ended earlyNCT01565148What this trial is testingA Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)Who this might be right forDiabetic Macular Edema Johns Hopkins University 185
Not applicableLooking for participantsNCT07038967What this trial is testingNon-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After PhacoemulsificationWho this might be right forNon-CenterDiabetic Macular EdemaPhacoemulsification Ain Shams University 50
Testing effectiveness (Phase 2)Study completedNCT03238963What this trial is testingA Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.Who this might be right forDiabetic Retinopathy Boehringer Ingelheim 79
Not applicableEnrolling By InvitationNCT05296447What this trial is testingLong-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic RetinopathyWho this might be right forDiabetic Retinopathy, DR AbbVie 100
Testing effectiveness (Phase 2)Study completedNCT02699450What this trial is testingFaricimab (RO6867461) in Participants With Center-Involving Diabetic Macular EdemaWho this might be right forDiabetic Macular Edema Hoffmann-La Roche 229
Testing effectiveness (Phase 2)WithdrawnNCT00457470What this trial is testingStudy Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)Who this might be right forDiabetes MellitusDiabetic Retinopathy Pfizer
Post-approval studies (Phase 4)Active Not RecruitingNCT07118670What this trial is testingHigh Dose Eylea for Proliferative Diabetic Retinopathy OutcomesWho this might be right forProliferative Diabetic Retinopathy (PDR) Edward Wood, MD 40
Not applicableWithdrawnNCT04428242What this trial is testingStudy Evaluating Retinal Health Monitoring System Thickness ModuleWho this might be right forMacular EdemaMacular Degeneration Kubota Vision Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06942520What this trial is testingPhase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)Who this might be right forDiabetic Macular Edema Sierra Eye Associates 18
Testing effectiveness (Phase 2)Study completedNCT03397264What this trial is testingA Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular EdemaWho this might be right forDiabetic Macular Edema Opthea Limited 153
Large-scale testing (Phase 3)Study completedNCT04288232What this trial is testingEfficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in TaiwanWho this might be right forCenter-involved Diabetic Macular Edema Taipei Veterans General Hospital, Taiwan 45
Testing effectiveness (Phase 2)Study completedNCT01319487What this trial is testingSafety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic RetinopathyWho this might be right forDiabetic Macular Edema Fovea Pharmaceuticals SA 267
Testing effectiveness (Phase 2)Study completedNCT01945866What this trial is testingPhase II Combination Steroid and Anti-VEGF for Persistent DMEWho this might be right forDiabetic Macular Edema Jaeb Center for Health Research 129
Not applicableLooking for participantsNCT07295704What this trial is testingMicropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular EdemaWho this might be right forMicropulse LaserTreatmentInitial+2 more The General Authority for Teaching Hospitals and Institutes 50